HOUSTON--(BUSINESS WIRE)--Power3 Medical Products Inc. (OTC: PWRM, www.Power3Medical.com), today announced the filing of another patent application – its seventh in the last 10 months -- for 47 new biomarkers it has discovered and validated for use in the early diagnosis and detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS.
